Viking Therapeutics CEO Brian Lian's 2021 pay falls 22% to $4.1M
Viking Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 7, 2022
Viking Therapeutics reported fiscal year 2021 executive compensation information on April 7, 2022.
In 2021, three executives at Viking Therapeutics received on average a compensation package of $2.3M, a 56% decrease compared to previous year.
Average pay of disclosed executives at Viking Therapeutics
Brian Lian, Chief Executive Officer, received $4.1M in total, which decreased by 22% compared to 2020. 41% of Lian's compensation, or $1.7M, was in stock awards. Lian also received $278K in non-equity incentive plan, $1.5M in option awards, as well as $594K in salary.
Marianne Mancini, Chief Operating Officer, received a compensation package of $1.5M. 40% of the compensation package, or $597K, was in stock awards.
Greg Zante, Chief Financial Officer, earned $1.3M in 2021.
Related executives
You may also like
Source: SEC filing on April 7, 2022.